AddiFab receives investment from Mitsubishi Chemical Holdings Corporation’s US venture arm

AddiFab has received investment from Mitsubishi Chemical Holdings Corporation’s (MCHC) U.S. venture arm Diamond Edge Ventures.

The Danish company is promising to bring to market a range of injection moulding materials to the additive manufacturing space through its Freeform Injection Molding (FIM) platform. FIM is able to process rubbers, thermoplastics, ceramics and hard metals, with the company committed to expanding this range further.

Those endeavours will now be supplemented by the backing of MCHC and Diamond Edge Ventures. The President of DEV, Patrick Suel, will also join the AddiFab Board of Directors.

“Our investment in AddiFab reflects MCHC’s dedication to the 3D printing community,” commented Suel. “FIM gives customers the flexibility and speed of 3D printing with the consistency and reliability of injection moulding. The industry can now rely on an existing and independent supply chain of existing and proven materials. We have already brought the tried and trusted materials from the DIAKON, KyronMAX, Ketron, Tefabloc and Trexprene into the additive world created by FIM and more will follow as a result of this collaboration.”

“This investment and development relationship with the MCHC Group companies, a worldwide leader in advanced, high-performance polymer materials, will strengthen the ecosystem of support for AddiFab and their customers for the global deployment of Freeform Injection Molding,” added Lasse Staal, AddiFab co-founder and CEO. “The collaborations with Mitsubishi Chemical will allow us to strengthen the Freeform Injection Platform while at the same time accelerating the pace of adoption of this transformative technology.”

AddiFab is exhibiting at TCT Show on Stand G83. 

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published.